CXC chemokine KC fails to induce neutrophil infiltration and neoangiogenesis in a mouse model of myocardial infarction

Journal of Molecular and Cellular Cardiology

Volumn 60, Issue 1, 2013, Pages 1-7

  Oral, Hasan ^a   Kanzler, Isabella ^a,b   Tuchscheerer, Nancy ^a   Curaj, Adelina ^a,c   Simsekyilmaz, Sakine ^a   Sönmez, Tolga Taha ^a   Radu, Eugen ^d   Postea, Otilia ^a   Weber, Christian ^a,e   Schuh, Alexander ^a   Liehn, Elisa A ^a  

^a RWTH AACHEN UNIVERSITY   (Germany)

^b GOETHE UNIVERSITY   (Germany)

^c VICTOR BABES NATIONAL INSTITUTE OF PATHOLOGY   (Romania)

^d CAROL DAVILA UNIVERSITY OF MEDICINE AND PHARMACY   (Romania)

^e LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

Angiogenesis; Chemokine; KC; Myocardial infarction; Neutrophils

Indexed keywords

ANTIBODY; CARDIOVASCULAR AGENT; KERATINOCYTE DERIVED CHEMOKINE; KERATINOCYTE DERIVED CHEMOKINE ANTIBODY; UNCLASSIFIED DRUG;

ANGIOGENESIS; ANIMAL CELL; ARTICLE; CARDIOVASCULAR RESPONSE; CONTROLLED STUDY; HEART EJECTION FRACTION; HEART INFARCTION; HEART INFARCTION SIZE; HEART LEFT VENTRICLE CONTRACTION; HEART LEFT VENTRICLE RELAXATION; HEART RATE; HEART WEIGHT; HISTOLOGY; IMMUNOHISTOCHEMISTRY; LEUKOCYTE ACTIVATION; MOUSE; NEUTROPHIL CHEMOTAXIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; SURVIVAL RATE;

ANGIOGENESIS INDUCING AGENTS; ANIMALS; ANTIBODIES; CHEMOKINE CXCL1; DISEASE MODELS, ANIMAL; MICE; MYOCARDIAL INFARCTION; NEOVASCULARIZATION, PHYSIOLOGIC; NEUTROPHIL INFILTRATION; NEUTROPHILS; TIME FACTORS;

ANIMALIA; MUS;

EID: 84877025343     PISSN: 00222828     EISSN: 10958584     Source Type: Journal    
DOI: 10.1016/j.yjmcc.2013.04.006     Document Type: Article

References (33)

1. Blankesteijn W.M., Creemers E., Lutgens E., Cleutjens J.P., Daemen M.J., Smits J.F. Dynamics of cardiac wound healing following myocardial infarction: observations in genetically altered mice. Acta Physiol Scand 2001, 173(1):75-82.
2. Frangogiannis N.G., Entman M.L. Chemokines in myocardial ischemia. Trends Cardiovasc Med 2005, 15(5):163-169.
3. Herskowitz A., Choi S., Ansari A.A., Wesselingh S. Cytokine mRNA expression in postischemic/reperfused myocardium. Am J Pathol 1995, 146(2):419-428.
4. Liehn E.A., Zernecke A., Postea O., Weber C. Chemokines: inflammatory mediators of atherosclerosis. Arch Physiol Biochem 2006, 112(4-5):229-238.
5. Frangogiannis N.G., Smith C.W., Entman M.L. The inflammatory response in myocardial infarction. Cardiovasc Res 2002, 53(1):31-47.
6. Jaeschke H., Smith C.W. Mechanisms of neutrophil-induced parenchymal cell injury. J Leukoc Biol 1997, 61(6):647-653.
7. Jordan J.E., Zhao Z.Q., Vinten-Johansen J. The role of neutrophils in myocardial ischemia-reperfusion injury. Cardiovasc Res 1999, 43(4):860-878.
8. Jolly S.R., Kane W.J., Hook B.G., Abrams G.D., Kunkel S.L., Lucchesi B.R. Reduction of myocardial infarct size by neutrophil depletion: effect of duration of occlusion. Am Heart J 1986, 112(4):682-690.
9. Romson J.L., Hook B.G., Kunkel S.L., Abrams G.D., Schork M.A., Lucchesi B.R. Reduction of the extent of ischemic myocardial injury by neutrophil depletion in the dog. Circulation 1983, 67(5):1016-1023.
10. Liehn E.A., Merx M.W., Postea O., Becher S., Djalali-Talab Y., Shagdarsuren E., et al. Ccr1 deficiency reduces inflammatory remodelling and preserves left ventricular function after myocardial infarction. J Cell Mol Med 2008, 12(2):496-506.
11. Lee J., Cacalano G., Camerato T., Toy K., Moore M.W., Wood W.I. Chemokine binding and activities mediated by the mouse IL-8 receptor. J Immunol 1995, 155(4):2158-2164.
12. Call D.R., Nemzek J.A., Ebong S.J., Bolgos G.R., Newcomb D.E., Wollenberg G.K., et al. Differential local and systemic regulation of the murine chemokines KC and MIP2. Shock (Augusta Ga) 2001, 15(4):278-284.
13. Chandrasekar B., Smith J.B., Freeman G.L. Ischemia-reperfusion of rat myocardium activates nuclear factor-KappaB and induces neutrophil infiltration via lipopolysaccharide-induced CXC chemokine. Circulation 2001, 103(18):2296-2302.
14. Belo A.V., Leles F., Barcelos L.S., Ferreira M.A., Bakhle Y.S., Teixeira M.M., et al. Murine chemokine CXCL2/KC is a surrogate marker for angiogenic activity in the inflammatory granulation tissue. Microcirculation 2005, 12(7):597-606.
15. Addison C.L., Daniel T.O., Burdick M.D., Liu H., Ehlert J.E., Xue Y.Y., et al. The CXC chemokine receptor 2, CXCR2, is the putative receptor for ELR+CXC chemokine-induced angiogenic activity. J Immunol 2000, 165(9):5269-5277.
16. Loukinova E., Dong G., Enamorado-Ayalya I., Thomas G.R., Chen Z., Schreiber H., et al. Growth regulated oncogene-alpha expression by murine squamous cell carcinoma promotes tumor growth, metastasis, leukocyte infiltration and angiogenesis by a host CXC receptor-2 dependent mechanism. Oncogene 2000, 19(31):3477-3486.
17. Strieter R.M., Polverini P.J., Kunkel S.L., Arenberg D.A., Burdick M.D., Kasper J., et al. The functional role of the ELR motif in CXC chemokine-mediated angiogenesis. J Biol Chem 1995, 270(45):27348-27357.
18. Tarzami S.T., Miao W., Mani K., Lopez L., Factor S.M., Berman J.W., et al. Opposing effects mediated by the chemokine receptor CXCR2 on myocardial ischemia-reperfusion injury: recruitment of potentially damaging neutrophils and direct myocardial protection. Circulation 2003, 108(19):2387-2392.
19. Liehn E.A., Schober A., Weber C. Blockade of keratinocyte-derived chemokine inhibits endothelial recovery and enhances plaque formation after arterial injury in ApoE-deficient mice. Arterioscler Thromb Vasc Biol 2004, 24(10):1891-1896.
20. Hristov M., Zernecke A., Bidzhekov K., Liehn E.A., Shagdarsuren E., Ludwig A., et al. Importance of CXC chemokine receptor 2 in the homing of human peripheral blood endothelial progenitor cells to sites of arterial injury. Circ Res 2007, 100(4):590-597.
21. Postea O., Koenen R.R., Hristov M., Weber C., Ludwig A. Homocysteine up-regulates vascular transmembrane chemokine CXCL16 and induces CXCR6+ lymphocyte recruitment in vitro and in vivo. J Cell Mol Med 2008, 12(5A):1700-1709.
22. Kobayashi Y. The role of chemokines in neutrophil biology. Front Biosci 2008, 13:2400-2407.
23. Rovai L.E., Herschman H.R., Smith J.B. The murine neutrophil-chemoattractant chemokines LIX, KC, and MIP-2 have distinct induction kinetics, tissue distributions, and tissue-specific sensitivities to glucocorticoid regulation in endotoxemia. J Leukoc Biol 1998, 64(4):494-502.
24. Pinckard R.N., Olson M.S., Giclas P.C., Terry R., Boyer J.T., O'Rourke R.A. Consumption of classical complement components by heart subcellular membranes in vitro and in patients after acute myocardial infarction. J Clin Invest 1975, 56(3):740-750.
25. Rossen R.D., Michael L.H., Hawkins H.K., Youker K., Dreyer W.J., Baughn R.E., et al. Cardiolipin-protein complexes and initiation of complement activation after coronary artery occlusion. Circ Res 1994, 75(3):546-555.
26. Vakeva A.P., Agah A., Rollins S.A., Matis L.A., Li L., Stahl G.L. Myocardial infarction and apoptosis after myocardial ischemia and reperfusion: role of the terminal complement components and inhibition by anti-C5 therapy. Circulation 1998, 97(22):2259-2267.
27. Distelmaier K., Adlbrecht C., Jakowitsch J., Winkler S., Dunkler D., Gerner C., et al. Local complement activation triggers neutrophil recruitment to the site of thrombus formation in acute myocardial infarction. Thromb Haemost 2009, 102(3):564-572.
28. Lee S.H., Wolf P.L., Escudero R., Deutsch R., Jamieson S.W., Thistlethwaite P.A. Early expression of angiogenesis factors in acute myocardial ischemia and infarction. N Engl J Med 2000, 342(9):626-633.
29. Penn M.S. Importance of the SDF-1:CXCR4 axis in myocardial repair. Circ Res 2009, 104(10):1133-1135.
30. Takahashi M. Role of the SDF-1/CXCR4 system in myocardial infarction. Circ J 2010, 74(3):418-423.
31. Lue H., Kleemann R., Calandra T., Roger T., Bernhagen J. Macrophage migration inhibitory factor (MIF): mechanisms of action and role in disease. Microbes Infec/Inst Pasteur 2002, 4(4):449-460.
32. Bernhagen J., Krohn R., Lue H., Gregory J.L., Zernecke A., Koenen R.R., et al. MIF is a noncognate ligand of CXC chemokine receptors in inflammatory and atherogenic cell recruitment. Nat Med 2007, 13(5):587-596.
33. Miller E.J., Li J., Leng L., McDonald C., Atsumi T., Bucala R., et al. Macrophage migration inhibitory factor stimulates AMP-activated protein kinase in the ischaemic heart. Nature 2008, 451(7178):578-582.